Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton

Clinical trial NCT00748046 · COMPLETED

Trial details

NCT number: NCT00748046
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Metastases Pharmacokinetics

Start date: 2008-08-01
Primary completion: 2009-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.